Abstract 5037: DARPins as powerful targeting agents for radioligand therapeutics
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-5037
Abstract: The development of effective radioligand therapeutics (RLTs) is frequently hampered by the lack of high-quality targeting agents that selectively deliver radioactive payloads to the site of disease while sparing healthy tissues. Antibodies can have high… read more here.
Keywords: radioligand therapeutics; affinity; targeting agents; darpin ... See more keywords